. Author manuscript; available in PMC: 2019 Feb 19.

Published in final edited form as: Occup Environ Med. 2017 Apr 24;74(7):521–527. doi: 10.1136/oemed-2016-103948

Table 3.

Clinical characteristics of the 147 participants with type 2 diabetes at their first diabetic examination. Two of the 149 subjects with type 2 diabetes developed ESRD prior to their first eligible diabetic examination, leaving 147 subjects followed for these outcomes.

Variable
Male n (%)	50 (34)
ESRD events (n)	29
Deaths (n)	48
Age (years)	37.9 (27.8–49.9)
BMI (kg/m²)	33.1 (29.4–37.3)
Cholesterol (mg/dl)	167 (146 to 189)
Triglycerides (mg/dl)	114 (98 to 130)
Hemoglobin A1c (%)^*	8.3 (6.5–9.9)
MAP (mmHg)	91 (83–100)
eGFR (ml/min/1.73 m²)	115 (101–128)
ACR (mg/g)^**	19 (10–71)
Follow-up Time for ESRD (yrs)	26.8 (16.0–32.4)
Follow-up Time for mortality (yrs)	29.4 (19.4–34.9)

Values are median (interquartile range) unless otherwise noted.

n=116 patients;

^**

n=52 patients. These patients were followed for the onset of ESRD or death without ESRD. ACR, urinary albumin-to-creatinine ratio; BMI, body mass index; eGFR, estimated glomerular filtration rate by the CKD-EPI equation; ESRD, end-stage renal disease; MAP, mean arterial pressure.